5th Edition of
International Public Health Conference
March 19-21, 2026 | Singapore
Phenotypic Prevention
To find compounds like small molecules, peptides, or RNAi that change the phenotype of a cell or an organism in a desirable way, phenotypic screening is a sort of screening used in biological research and drug development. To understand how a phenotypic hit functions, phenotypic screening must be followed by identification and confirmation, frequently using chemoproteomics. Historically, medication discovery has been based on phenotypic screening. Compounds are tested in cellular or animal illness models to find those that result in a desired change in phenotype. The procedure of target deconvolution is used to identify the biological targets of chemicals only after they have been found. This comprehensive plan is known as target deconvolution. This overall strategy is referred to as "classical pharmacology", "forward pharmacology" or "phenotypic drug discovery" (PDD).
David John Wortley
International Society of Digital Medicine (ISDM), United Kingdom
Bob Esquerre
Esquerre Fitness Group International, United States
Kyrisakos Kouveliotis
Berlin School of Business and Innovation, GermanySubmit your abstract Today
Title : Spillover at the edge: Mapping zoonotic disease risk in the wildland-urban interface
Roman Sharnuud, University of Tennessee, United States
Title : AI for good? Expanding our understanding of opinion leaders in a changing digital landscape
Amelia Burke Garcia, NORC at the University of Chicago, United States
Title : Confidence as care: Empowering under represented voices in public health leadership and community engagement
Sheena Yap Chan, The Tao of Self-Confidence, Canada
Title : Redefining eHealth literacy for the digital age: A scoping review to advance equity, engagement, and behaviour change
Comfort Sanuade, Concordia University, Canada
Title : Innovative approaches in public health leadership: Empowering communities for resilient health systems
Mohammad Kamal Hussain, Umm Al-Qura University, Saudi Arabia
Title : Assessing human exposure to key chemical carcinogens diagnostic approaches and interpretation
Vladan Radosavljevic, Military Medical Academy, Serbia